+Search query
-Structure paper
Title | Discovery of a Novel, Highly Potent, and Selective Thieno[3,2-d]pyrimidinone-Based Cdc7 Inhibitor with a Quinuclidine Moiety (TAK-931) as an Orally Active Investigational Antitumor Agent. |
---|---|
Journal, issue, pages | J. Med. Chem., Vol. 63, Page 1084-1104, Year 2020 |
Publish date | May 30, 2019 (structure data deposition date) |
![]() | Kurasawa, O. / Miyazaki, T. / Homma, M. / Oguro, Y. / Imada, T. / Uchiyama, N. / Iwai, K. / Yamamoto, Y. / Ohori, M. / Hara, H. ...Kurasawa, O. / Miyazaki, T. / Homma, M. / Oguro, Y. / Imada, T. / Uchiyama, N. / Iwai, K. / Yamamoto, Y. / Ohori, M. / Hara, H. / Sugimoto, H. / Iwata, K. / Skene, R. / Hoffman, I. / Ohashi, A. / Nomura, T. / Cho, N. |
![]() | ![]() ![]() |
Methods | X-ray diffraction |
Resolution | 2.65 - 3.3 Å |
Structure data | ![]() PDB-6p5m: ![]() PDB-6p5p: |
Chemicals | ![]() ChemComp-O1S: ![]() ChemComp-HOH: ![]() ChemComp-O1V: |
Source |
|
![]() | TRANSFERASE/TRANSFERASE INHIBITOR / Kinase / Inhibitor / Oral / Anti-tumor / TRANSFERASE-TRANSFERASE INHIBITOR / TRANSFERASE-TRANSFERASE INHIBITOR complex |